Biography
Dr. Tommaso Pollini, M.D. is a post-doctoral research fellow at the University of California, San Francisco (UCSF) in the Maker Lab, specializing in pancreatic cystic neoplasms with a focus on Intraductal Papillary Mucinous Neoplasms (IPMN). He completed his surgical training at the Pancreas Institute of the University of Verona, Italy, where he developed a solid foundation in pancreatic diseases. Recognized for his contributions to the field, Dr. Pollini received the prestigious Kenneth Warren Fellowship from the International Hepato-Pancreato-Biliary Association and the Steve Sotsky Award from the American Hepato-Pancreato-Biliary Association.
At UCSF, his research centers on developing predictive models for high-grade dysplasia in pancreatic cystic tumors using machine learning. Utilizing his expertise in bioinformatics, single-nucleus RNA sequencing (snRNAseq), and spatial transcriptomics, he studies the tumor immune microenvironment of pancreatic cancers. Dr. Pollini has published his work in leading journals such as JAMA Surgery, The Lancet Gastroenterology & Hepatology, and Gastroenterology, contributing significantly to advancements in pancreatic cancer research.
Education
Institution | Degree | Dept or School | End Date |
---|---|---|---|
University of Verona | General Surgery Residency | 01/2023 | |
University of Verona | Research Fellow at the Department of General and Pancreatic Surgery of the Pancreas Institute | 12/2017 | |
University of Verona | MD | Medicine | 10/2015 |
Awards & Honors
Award | Conferred By | Date |
---|---|---|
Kenneth Warren Fellowship | International Hepato-Pancreato-Biliary Association (IHPBA) | 2021/2022 |
Steve Sotksi Award | American Hepato-Pancreato-Biliary Association (AHPBA) | 2021 |
Publications
- The faith of non-surveilled pancreatic cysts: a bicentric retrospective study.| | PubMed
- Systematic review and meta-analysis of observational studies on BD-IPMNS progression to malignancy.| | PubMed
- Serous Cystic Neoplasms of the Pancreas Management in the Real-world: Still Operating on a Benign Entity.| | PubMed
- Hypofractionated Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost and Simultaneous Integrated Protection in Pancreatic Ductal Adenocarcinoma.| | PubMed
- Prognostic Impact of Preoperative Nutritional Risk in Patients Who Undergo Surgery for Pancreatic Adenocarcinoma.| | PubMed
- Epidemiology, clinical features and diagnostic work-up of cystic neoplasms of the pancreas: Interim analysis of the prospective PANCY survey.| | PubMed
- Branch Duct Intraductal Papillary Mucinous Neoplasms: Recommendations for Follow-Up and Surgery.| | PubMed
- "Trivial" Cysts Redefine the Risk of Cancer in Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Potential Target for Follow-Up Discontinuation?| | PubMed
- The management of intraductal papillary mucinous neoplasms of the pancreas.| | PubMed
- The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution.| | PubMed